Konstantin Ranev is a highly experienced market access and reimbursement specialist in the Japanese healthcare landscape. With deep knowledge of policy impact analysis, he has proven expertise in gathering insights on market access, payer research, reimbursement and pricing of pharmaceuticals and medical devices in Japan. Konstantin has extensive connections with KOL's and payers, as well as rare target groups such as Japanese patients with rare/intractable diseases. Through his expertise, Konstantin is able to provide comprehensive strategic guidance to clients regarding reimbursement and market access, as well as the impact of policy changes on the industry.